Bausch + Lomb announced the acquisition of the ELIOS system, a laser-based technology that offers a new approach to treating ...

The global glaucoma treatment market is projected to grow from USD 5.7 billion in 2022 to USD 8.0 billion by 2033, at a CAGR ...

Here, we're detailing what exactly glaucoma is, plus the most common glaucoma treatment options that can help preserve your ...

Advanced tools are being deployed by Duke Health and others in the fight against vision loss. STORY HIGHLIGHTS Half of ...

Many eye conditions can be easily treated if those at risk undergo regular eye examinations, and are informed about good ...

Textbook of ophthalmology, vol 7, Glaucoma. London: Mosby, 1994. Levobunolol Study Group. Levobunolol: a beta adrenoreceptor antagonist effective in the long term treatment of glaucoma.

a CBN-based topical eye drop formulation for the treatment of glaucoma; and additional discovery programs utilizing CBN and other rare cannabinoids. This growing pipeline places InMed at the ...

A dedicated FAQ section is available for common drugs to address questions and provide a deeper understanding of Glaucoma management options. Remember to consult your healthcare provider for ...

At Mass Eye and Ear, experts said treatment options for glaucoma have improved in recent years. “Glaucoma these days is not the same as it was 10 to 20 years ago. We also have laser-based ...

Global Glaucoma Therapeutics Market Poised for Growth; Set to Reach US$7.2 Billion by 2030 Glaucoma Therapeutics Market ...

"As the leader in eye care, Alcon will continue to invest in R&D to expand our broad portfolio of glaucoma treatment options and to further reduce the burden of this silent, sight-threatening ...